UNH vs CVS
UnitedHealth Group Incorporated vs CVS Health Corporation · Updated Mar 28, 2026
UNH — 10 winsCVS — 13 wins
Price Performance
UNH -49.81%CVS +4.38%
Performance
| UNH | CVS | |
|---|---|---|
| 1 Month | -9.70% | -9.97% |
| 3 Months | -20.99% | -11.24% |
| 6 Months | -27.05% | -5.87% |
| YTD | -22.26% | -11.50% |
| 1 Year | -50.02% | +4.51% |
| 3 Year | -50.73% | -23.85% |
| 5 Year | -15.25% | +9.87% |
Yearly Returns
| YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNH | -23.0% | -35.6% | -6.2% | +1.5% | +5.5% | +43.7% | +19.9% | +20.7% | +12.6% | +36.5% | +37.4% | +16.7% |
| CVS | -12.5% | +79.5% | -44.5% | -15.0% | -10.5% | +48.1% | -7.9% | +13.3% | -10.9% | -9.8% | -18.2% | +2.8% |
Valuation
| UNH | CVS | |
|---|---|---|
| P/E Ratio | 19.44 | 50.89 |
| Forward P/E | 15.92 | 10.13 |
| PEG Ratio | 1.95 | 3.66 |
| P/S Ratio | 0.56 | 0.23 |
| P/B Ratio | 2.50 | 1.21 |
| EV/EBITDA | 13.19 | 17.85 |
Financials
| UNH | CVS | |
|---|---|---|
| EPS (TTM) | $13.20 | $1.38 |
| Gross Margin | +88.80% | +12.84% |
| Operating Margin | +0.34% | +2.00% |
| Net Margin | +0.19% | +2.78% |
| ROE | +12.80% | +2.32% |
| ROA | +4.14% | +0.67% |
| Debt/Equity | 0.78 | 1.24 |
Growth
| UNH | CVS | |
|---|---|---|
| Revenue Growth YoY | +12.31% | +8.17% |
| Revenue Growth QoQ | +0.05% | +2.74% |
| EPS Growth YoY | -99.67% | +76.92% |
| EPS Growth QoQ | -99.23% | +173.48% |
Technical
| UNH | CVS | |
|---|---|---|
| RSI (14) | 32.10 | 30.71 |
| % From 20-Day SMA | -8.73% | -6.76% |
| % From 50-Day SMA | -12.20% | -8.43% |
| % From 200-Day SMA | -18.14% | -5.50% |
| % From 52-Week High | -57.68% | -17.52% |
| % From 52-Week Low | +9.39% | +20.36% |
Analyst Ratings
UNH
Buy(25 analysts)
Strong SellHoldStrong Buy
Price Target
$385.38
+38.68% upside
CVS
Buy(24 analysts)
Strong SellHoldStrong Buy
Price Target
$95.15
+34.00% upside
Overview
| UNH | CVS | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Medical - Healthcare Plans | Medical - Healthcare Plans |
| Exchange | NYSE | NYSE |
| Market Cap | $250.15B | $90.94B |
| Shares Outstanding | 907.7M | 1.27B |
| Avg Volume (10D) | 9.93M | 7.91M |
| Dividend Yield | 3.21% | 3.72% |
Frequently Asked Questions
Is UNH or CVS a better buy right now?
Based on 23 comparable metrics, CVS leads in 13 categories while UNH leads in 10. CVS has a consensus analyst rating with 24 analysts covering the stock. Neither stock should be purchased based on a single comparison — consider your investment goals and risk tolerance.
Which stock has better performance, UNH or CVS?
Over the past year, UNH returned -50.02% compared to CVS's +4.51%. In the short term (1 month), UNH returned -9.70% vs CVS's -9.97%.
Is UNH or CVS more expensive?
UNH trades at a P/E of 19.44 compared to CVS's 50.89. On a price-to-sales basis, UNH trades at 0.56x vs CVS's 0.23x. Forward P/E: UNH at 15.92 vs CVS at 10.13.
Which stock has higher growth, UNH or CVS?
UNH's revenue grew +12.31% year-over-year compared to CVS's +8.17%. EPS growth: UNH at -99.67% vs CVS at +76.92%.
Do UNH and CVS pay dividends?
UNH pays a dividend with a yield of 3.21%. CVS pays a dividend with a yield of 3.72%.
Which stock do analysts prefer, UNH or CVS?
UNH has 25 analysts with a target price of $385.38 (+38.68% upside). CVS has 24 analysts with a target of $95.15 (+34.00% upside).
Data updated daily. All comparisons based on latest available market data. Not investment advice.